Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (27)
Lin Zhou, Zhe Zhang, Yizhou Tian, Zefei Li, Zhongliang Liu & Sibo Zhu. (2023) The critical role of platelet in cancer progression and metastasis. European Journal of Medical Research 28:1.
Crossref
Crossref
Christopher Johns, Steven K. Montalvo, M’Kay Cauble, Yu-Lun Liu, Sean All, Asal S. Rahimi, Prasanna G. Alluri, Marilyn Leitch, Nisha Unni, Rachel Wooldridge, Deborah Farr, Chika Nwachukwu & D. W. Nathan Kim. (2023) Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy. Breast Cancer Research and Treatment 199:2, pages 381-387.
Crossref
Crossref
Christopher Johns, Allen Yen, Asal Rahimi, Yu-Lun Liu, Ann Marilyn Leitch, Ann Spangler, Prasanna Alluri, Chika Nwachukwu, Rachel Wooldridge, Deborah Farr & D. W. Nathan Kim. (2023) Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients. Journal of Breast Cancer 26:1, pages 14.
Crossref
Crossref
Violetta Dymicka-Piekarska, Olga M. Koper-Lenkiewicz, Justyna Zińczuk, Ewa Kratz & Joanna Kamińska. (2020) Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs). Cancer Immunology, Immunotherapy 70:6, pages 1497-1510.
Crossref
Crossref
Joshua E. Lewis & Melissa L. Kemp. (2021) Integration of machine learning and genome-scale metabolic modeling identifies multi-omics biomarkers for radiation resistance. Nature Communications 12:1.
Crossref
Crossref
Phuong H.L. Tran, Beom-Jin Lee & Thao T.D. Tran. (2021) Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen its Therapeutic Application in Cancer. Current Pharmaceutical Design 27:18, pages 2209-2220.
Crossref
Crossref
Lukas Werner Prause, Lukas Manka, Christopher Millan, Elena Lang, Stephen F. Wyler, Rainer Grobholz, Angelika Hammerer-Lercher, Tullio Sulser, Franz Recker, Maciej Kwiatkowski & Daniel Eberli. (2019) Influence of regular aspirin intake on PSA values, prostate cancer incidence and overall survival in a prospective screening trial (ERSPC Aarau). World Journal of Urology 38:10, pages 2485-2491.
Crossref
Crossref
Jiatong Zhou, Shuai Xia, Tao Li & Ranlu Liu. (2019) Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis. BMC Cancer 19:1.
Crossref
Crossref
Birgit Ritter & Florian R. Greten. (2019) Modulating inflammation for cancer therapy. Journal of Experimental Medicine 216:6, pages 1234-1243.
Crossref
Crossref
Lai lai Fan, Cheng Peng Xie, Yi Ming Wu, Xi jie Gu, Ying he Chen & Yi jun Wang. (2019) Aspirin Exposure and Mortality Risk among Prostate Cancer Patients: A Systematic Review and Meta-Analysis. BioMed Research International 2019, pages 1-15.
Crossref
Crossref
Lindsay A. Broadfield, Katarina Marcinko, Evangelia Tsakiridis, Panayiotis G. Zacharidis, Linda Villani, James S. V. Lally, Gabe Menjolian, Danitra Maharaj, Tammy Mathurin, Marcia Smoke, Thomas Farrell, Paola Muti, Gregory R. Steinberg & Theodoros Tsakiridis. (2019) Salicylate enhances the response of prostate cancer to radiotherapy. The Prostate 79:5, pages 489-497.
Crossref
Crossref
Mohammad K. Khan, Tahseen H. Nasti, Zachary S. Buchwald, Ralph R. Weichselbaum & Stephen J. Kron. (2019) Repurposing Drugs for Cancer Radiotherapy. The Cancer Journal 25:2, pages 106-115.
Crossref
Crossref
Yuxiang Sun, Hui Dai, Shaopeng Chen, Yajun Zhang, Tao Wu, Xianbin Cao, Guoping Zhao, An Xu, Jun Wang & Lijun Wu. (2018) Disruption of Chromosomal Architecture of cox2 Locus Sensitizes Lung Cancer Cells to Radiotherapy. Molecular Therapy 26:10, pages 2456-2465.
Crossref
Crossref
Divyesh Thakker, AmitD Raval, Nilixa Raval & Ami Vyas. (2018) Nonsteroidal anti-inflammatory drugs and clinical outcomes among men with prostate cancer: A systematic review and meta-analysis. Indian Journal of Medical and Paediatric Oncology 39:2, pages 127.
Crossref
Crossref
Tsuyoshi Takiuchi, Erin A. Blake, Koji Matsuo, Anil K. Sood & Theodore M. Brasky. (2018) Aspirin use and endometrial cancer risk and survival. Gynecologic Oncology 148:1, pages 222-232.
Crossref
Crossref
Cheryl Jacobs Smith, Tiffany H. Dorsey, Wei Tang, Symone V. Jordan, Christopher A. Loffredo & Stefan Ambs. (2017) Aspirin Use Reduces the Risk of Aggressive Prostate Cancer and Disease Recurrence in African-American Men. Cancer Epidemiology, Biomarkers & Prevention 26:6, pages 845-853.
Crossref
Crossref
Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker & Kenneth V. Honn. (2017) Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?. Cancer and Metastasis Reviews 36:2, pages 305-329.
Crossref
Crossref
Xiaoping Zhao, Zhi Xu & Haoseng Li. (2017) NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
J. Shiao, K. M. Thomas, A. S. Rahimi, R. Rao, Jingsheng Yan, Xian-Jin Xie, M. DaSilva, A. Spangler, M. Leitch, R. Wooldridge, A. Rivers, D. Farr, B. Haley & D. W. Nathan Kim. (2016) Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Research and Treatment 161:3, pages 463-471.
Crossref
Crossref
Daniel Bar, Ofer Lavie, Nili Stein, Ido Feferkorn & Ayelet Shai. (2016) The effect of metabolic comorbidities and commonly used drugs on the prognosis of patients with ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 207, pages 227-231.
Crossref
Crossref
Michel Zimmermann, Guila Delouya, Maroie Barkati, Shanie Campeau, Denis Rompotinos & Daniel Taussky. (2016) Impact of visceral fat volume and fat density on biochemical outcome after radical prostatectomy and postoperative radiotherapy. Hormone Molecular Biology and Clinical Investigation 26:3, pages 173-178.
Crossref
Crossref
Olga A. Martin, Xiaoyu Yin, Helen B. Forrester, Carl N. Sprung & Roger F. Martin. (2016) Potential strategies to ameliorate risk of radiotherapy-induced second malignant neoplasms. Seminars in Cancer Biology 37-38, pages 65-76.
Crossref
Crossref
Peter C. Elwood, Gareth Morgan, Janet E. Pickering, Julieta Galante, Alison L. Weightman, Delyth Morris, Mark Kelson & Sunil Dolwani. (2016) Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies. PLOS ONE 11:4, pages e0152402.
Crossref
Crossref
Virginia Wedell Osborn, Shan-Chin Chen, Joseph Weiner, David Schwartz & David Schreiber. (2015) Impact of Aspirin on Clinical Outcomes for African American Men with Prostate Cancer Undergoing Radiation. Tumori Journal 102:1, pages 65-70.
Crossref
Crossref
V. L. Serebruany, V. Cherepanov, H. A. Cabrera-Fuentes & M. H. Kim. (2015) Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. Thrombosis and Haemostasis 114:6, pages 1104-1112.
Crossref
Crossref
Jonathan Assayag, Michael N. Pollak & Laurent Azoulay. (2015) The Use of Aspirin and the Risk of Mortality in Patients with Prostate Cancer. The Journal of Urology 193:4, pages 1220-1225.
Crossref
Crossref
Boris Pasche, Minghui Wang, Michael Pennison & Hugo Jimenez. (2014) Prevention and Treatment of Cancer With Aspirin: Where Do We Stand?. Seminars in Oncology 41:3, pages 397-401.
Crossref
Crossref